Sorafenib-Induced Eruption Mimicking Erythema Multiforme.
Publication
, Journal Article
Pichard, DC; Cardones, AR; Chu, EY; Dahut, WL; Kong, HH
Published in: JAMA Dermatol
February 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA Dermatol
DOI
EISSN
2168-6084
Publication Date
February 2016
Volume
152
Issue
2
Start / End Page
227 / 228
Location
United States
Related Subject Headings
- Sorafenib
- Phenylurea Compounds
- Niacinamide
- Male
- Humans
- Erythema Multiforme
- Drug Eruptions
- Antineoplastic Agents
- Aged
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Pichard, D. C., Cardones, A. R., Chu, E. Y., Dahut, W. L., & Kong, H. H. (2016). Sorafenib-Induced Eruption Mimicking Erythema Multiforme. JAMA Dermatol, 152(2), 227–228. https://doi.org/10.1001/jamadermatol.2015.2930
Pichard, Dominique C., Adela R. Cardones, Emily Y. Chu, William L. Dahut, and Heidi H. Kong. “Sorafenib-Induced Eruption Mimicking Erythema Multiforme.” JAMA Dermatol 152, no. 2 (February 2016): 227–28. https://doi.org/10.1001/jamadermatol.2015.2930.
Pichard DC, Cardones AR, Chu EY, Dahut WL, Kong HH. Sorafenib-Induced Eruption Mimicking Erythema Multiforme. JAMA Dermatol. 2016 Feb;152(2):227–8.
Pichard, Dominique C., et al. “Sorafenib-Induced Eruption Mimicking Erythema Multiforme.” JAMA Dermatol, vol. 152, no. 2, Feb. 2016, pp. 227–28. Pubmed, doi:10.1001/jamadermatol.2015.2930.
Pichard DC, Cardones AR, Chu EY, Dahut WL, Kong HH. Sorafenib-Induced Eruption Mimicking Erythema Multiforme. JAMA Dermatol. 2016 Feb;152(2):227–228.
Published In
JAMA Dermatol
DOI
EISSN
2168-6084
Publication Date
February 2016
Volume
152
Issue
2
Start / End Page
227 / 228
Location
United States
Related Subject Headings
- Sorafenib
- Phenylurea Compounds
- Niacinamide
- Male
- Humans
- Erythema Multiforme
- Drug Eruptions
- Antineoplastic Agents
- Aged
- 1112 Oncology and Carcinogenesis